37.800
−4,30%
2026-10-19
Fundamental Analysis
85 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +40.4% | +200.3% | 3 / 3 | -14.4% | +10.80 pp | +14.77 pp | +31.0% | 0.00 | 3.75 | 51,5 | −14,4% | 19,8 | +39,2% | 3.75 | 11.19 | −66,5% |
| Pts | 8 | 12 | 12 | 0 | 12 | 12 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 37.800 (close price on 2026-10-19)EPS (TTM): 10.081
Financial charts
1.Revenue & growth
VND bn51,5Q2/26
1.Revenue & growth
VND bn51,5Q2/26
2.Profit & growth
VND bn19,9Q2/26
3.Profit mix (Penman)
VND bn170Q2/26
4.Margins & cost structure
%59.0%Q2/26
5.Returns & cash cycle
% · days33.3%Q2/26
6.Earnings quality & cash
VND bn81,4Q2/26
7.Asset structure
VND bn628Q2/26
8.Funding & debt health
VND bn · times628Q2/26
9.Revenue backlog
VND bn4,70Q2/26
10.Valuation
times · %3,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.471Q2/26
Adjusted EPS growth, latest quarter
40.4%
Average adjusted EPS growth, 3 quarters
200%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26